DEUTERX Trademark

Trademark Overview

On Friday, May 8, 2020, a trademark application was filed for DEUTERX with the United States Patent and Trademark Office. The USPTO has given the DEUTERX trademark a serial number of 88907118. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 4, 2023. This trademark is owned by DeuteRx, LLC. The DEUTERX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, cardiovascular, cardiopulmonary, genitourinary, oncological, hematological, ophthalmic, respiratory, neurological, gastrointestinal and immune system related diseases and disorders
deuterx

General Information

Serial Number88907118
Word MarkDEUTERX
Filing DateFriday, May 8, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 4, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 8, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, cardiovascular, cardiopulmonary, genitourinary, oncological, hematological, ophthalmic, respiratory, neurological, gastrointestinal and immune system related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 20, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDeuteRx, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressAndover, MA 01810
Party NameDeuteRx, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressAndover, MA 01810

Trademark Events

Event DateEvent Description
Monday, December 4, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 4, 2023ABANDONMENT - NO USE STATEMENT FILED
Saturday, April 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 14, 2023SOU EXTENSION 5 GRANTED
Friday, April 7, 2023SOU EXTENSION 5 FILED
Friday, April 14, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, April 7, 2023SOU TEAS EXTENSION RECEIVED
Thursday, October 13, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 11, 2022SOU EXTENSION 4 GRANTED
Tuesday, October 11, 2022SOU EXTENSION 4 FILED
Tuesday, October 11, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, April 6, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 4, 2022SOU EXTENSION 3 GRANTED
Monday, April 4, 2022SOU EXTENSION 3 FILED
Monday, April 4, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, October 20, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 18, 2021SOU EXTENSION 2 GRANTED
Monday, October 18, 2021SOU EXTENSION 2 FILED
Monday, October 18, 2021SOU TEAS EXTENSION RECEIVED
Thursday, April 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 20, 2021SOU EXTENSION 1 GRANTED
Tuesday, April 20, 2021SOU EXTENSION 1 FILED
Tuesday, April 20, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, November 3, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 8, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 8, 2020PUBLISHED FOR OPPOSITION
Wednesday, August 19, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 4, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 4, 2020ASSIGNED TO EXAMINER
Wednesday, May 20, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 12, 2020NEW APPLICATION ENTERED

Related Keywords

deuterx gastrointestinal neurological respiratory ophthalmic immune system disorders diseases related hematological